CMS issues contractor instructions for the CY 2027 ESRD PPS: low-volume adjustment tiers and December 31, 2026 attestation deadline
Published November 15, 2026 · Coverage November 8–14, 2026, Pacific · High priority
On November 12, 2026 CMS issued Transmittal R14043BP (Change Request 14638), the annual update that implements the calendar year (CY) 2027 End-Stage Renal Disease (ESRD) Prospective Payment System (PPS) rate updates and policies for Medicare contractors, effective January 1, 2027 with implementation January 4, 2027. It states the CY 2027 base rate of $297.52, expands the low-volume payment adjustment (LVPA) to facilities furnishing fewer than 8,000 treatments in each of the past three cost-reporting years, in six tiers, and extends the LVPA attestation deadline to December 31, 2026: facilities must attest by that date to receive the adjustment for payment year 2027, unless extraordinary circumstances justify an exception. It directs Medicare contractors to extend the attestation deadline for payment year 2027 to December 31, 2026. A companion systems transmittal, R13909CP (Change Request 14551), dated August 7, 2026, was re-communicated on November 13, 2026, with a note that it may now be posted publicly; the CMS transmittals index lists it with an issue date of November 12, 2026. On November 15, 2026 the Federal Register record for the rule still gave an effective date of January 1, 2027 and listed no corrections.

Background
CMS published the CY 2027 ESRD PPS final rule, Federal Register document 2026-22194, on October 30, 2026, effective January 1, 2027. The rule sets the unadjusted bundled payment base rate at $297.52 per treatment, up from $281.71 in 2026, and an eligible facility seeking the low-volume adjustment for payment year 2027 must provide its attestation by December 31, 2026.
Who this affects
ESRD facilities billing Medicare, including dialysis they furnish to beneficiaries with acute kidney injury (AKI).
Why it matters
The December 31, 2026 attestation date is now also in the Medicare contractor instruction, so an eligible facility that misses it should not expect the payment year 2027 adjustment unless its contractor grants an extraordinary-circumstance exception (inference). Tier assignment depends on the median treatment count over the past three cost-reporting years, which finance teams can now check against the published tiers.
Required actions
- For payment year 2027, an eligible ESRD facility seeking the low-volume adjustment must attest to its Medicare Administrative Contractor (MAC) by 2026-12-31, unless extraordinary circumstances justify an exception (conditional, not universal).
Recommended action
- Revenue-cycle and finance: model the rate and geographic adjustment against actual treatment mix; separately assess LVPA eligibility, ownership aggregation, cost-report history and tier; prepare the attestation before the deadline if seeking payment.
- Pharmacy, clinical and contracting: assess binder procurement, supply and transitions for eligible ESRD and AKI patients.
- Home-dialysis leaders: review training capacity, billing configuration and backup-support arrangements.
- Quality and laboratory: map the first pre-dialysis monthly phosphorus value into End-Stage Renal Disease Quality Reporting System (EQRS) workflows, check continuity and exclusions, validate historical data.
- Track CMS and Medicare Administrative Contractor (MAC) implementation guidance; confirm existing requirements remain before discontinuing a prior ESRD Quality Incentive Program (QIP) reporting process.
Implementation playbook
- Confirm whether each dialysis facility falls under the expanded low-volume threshold (fewer than 8,000 treatments in each of the past three cost-reporting years, with the other eligibility criteria unchanged) and which of the six tiers applies, from the median treatment count over the past three cost-reporting years. Owner: Finance. Due: 2026-12-01.
- Prepare and send the payment year 2027 low-volume attestation to the MAC for each eligible facility seeking the adjustment. Owner: Revenue Cycle and Finance. Due: 2026-12-15, ahead of the December 31, 2026 deadline.
- Load the CY 2027 base rate of $297.52 and confirm billing systems are ready for the January 4, 2027 contractor implementation. Owner: Revenue Cycle. Due: 2026-12-31.
- Watch the MAC's site for any notice on the attestation. Owner: Revenue Cycle. Due: 2026-12-01, then weekly through December 31, 2026.
Scope and timing
- Authority status
- Final
- Responsible owner
- Revenue Cycle and Finance (primary); affected: Pharmacy, Clinical Operations, Contracting, Home Dialysis, Quality, Laboratory
- Publication date
- 2026-10-30
- Effective date
- 2027-01-01
- Compliance date
- 2026-12-31 (low-volume adjustment attestation, eligible facilities seeking the adjustment)
- Implementation date
- 2027-01-04 (Medicare contractor implementation of Transmittal R14043BP, CR 14638)
- Other dates
- Temporary pediatric ESRD add-on ends 2026-12-31; QIP changes begin with payment year 2029; Transmittal R14043BP issued 2026-11-12; Transmittal R13909CP dated 2026-08-07, re-communicated 2026-11-13
Not established
Final ESRD Quality Reporting System (EQRS) technical specifications and any Noridian notice on the attestation were not checked.
Earlier article: November 8, 2026 edition →
Sources
- Federal Register 2026-22194
- CMS fact sheet CMS-1846-F
- Federal Register document record, CY 2027 ESRD PPS final rule (2026-22194)
- CMS 2026 Transmittals list, page 1 (25 of 296, newest issue dates first)
- CMS Transmittal R14043BP (CR 14638), CY 2027 ESRD PPS and AKI dialysis payment changes
- CMS Transmittal R13909CP (CR 14551), CY 2027 ESRD PPS system changes, re-communicated
- Federal Register search, all CMS documents published 2026-11-08 to 2026-11-14
Complete edition and supplemental material
This article in the complete report →
Executive triage, source-coverage limitations, context and forward horizons remain in the complete report.
Read the entire Medicare & Medicaid Sweep report →